$539 Million is the total value of Column Group LLC's 7 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NGM | Buy | NGM Biopharmaceuticals Inc | $247,749,000 | -9.1% | 16,245,817 | +5.5% | 45.93% | +23.9% |
| Tenaya Therapeutics, Inc. | $110,735,000 | -37.8% | 9,400,290 | 0.0% | 20.53% | -15.3% | ||
| RVMD | Revolution Medicines Inc | $85,388,000 | +1.4% | 3,347,245 | 0.0% | 15.83% | +38.2% | |
| RAPT | RAPT Therapeutics Inc | $30,830,000 | -40.1% | 1,402,008 | 0.0% | 5.72% | -18.4% | |
| Surrozen, Inc. | $28,339,000 | -53.3% | 9,414,795 | 0.0% | 5.25% | -36.3% | ||
| ORIC | ORIC Pharmaceuticals Inc. | $19,054,000 | -63.7% | 3,568,181 | 0.0% | 3.53% | -50.5% | |
| eFFECTOR Therapeutics Inc | $17,280,000 | -51.6% | 4,309,329 | 0.0% | 3.20% | -34.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NGM Biopharmaceuticals Inc | 12 | Q3 2023 | 52.5% |
| Revolution Medicines Inc | 12 | Q3 2023 | 36.3% |
| RAPT Therapeutics Inc | 12 | Q3 2023 | 29.6% |
| ORIC Pharmaceuticals Inc. | 12 | Q3 2023 | 14.6% |
| Tenaya Therapeutics, Inc. | 9 | Q3 2023 | 24.2% |
| Surrozen, Inc. | 9 | Q3 2023 | 8.2% |
| eFFECTOR Therapeutics Inc | 9 | Q3 2023 | 6.9% |
| Constellation Pharmaceuticals Inc. | 3 | Q2 2021 | 12.6% |
| Nurix Therapeutics Inc | 2 | Q1 2021 | 16.1% |
| Gritstone Oncology Inc | 1 | Q4 2020 | 0.3% |
View Column Group LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-07-24 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 4 | 2022-05-27 |
| 4 | 2022-05-25 |
| 13F-HR | 2022-05-16 |
View Column Group LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.